Search results for: Category

Baylor Scott & White research team receives ‘Paper of the Year’ award for groundbreaking work on health disparities

African American women have higher rates of diabetes and obesity than White women, increasing their risk for multiple chronic diseases. Although lifestyle interventions such as diet and exercise can help, African American women also tend to benefit less from these interventions than White women. Baylor Scott & White Research Institute researcher Heather Kitzman, PhD, had the important idea that faith-based interventions may be more successful than typical interventions to engage African American women in weight loss and other healthy behaviors. Her team’s publication on this work was recently honored with the Dorothy Nyswander 2021 Paper of the Year Award from the American Journal of Health Promotion.

Read more

Research team looks to establish new dementia caregiver support solutions

Caring for family members with dementia and other forms of Alzheimer’s disease is a difficult task, and it is common for caregivers to feel overwhelmed due to the physical and emotional demands of the role. Researchers at Baylor Scott & White Research Institute’s (BSWRI) Center for Applied Health Research (CAHR) are engaged in groundbreaking studies to understand how to improve the quality of life for these caregivers. This work has taken on even greater implications now as COVID-19 creates greater isolation for caregivers making their role even more challenging.

Read more

Next generation total artificial heart as bridge to transplant in landmark trial at BSW

Baylor Scott & White Research Institute was recently selected as one of only seven sites in the nation to participate in the landmark feasibility study of the Carmat Total Artificial Heart (TAH) for transplant-eligible patients in severe, end-stage heart failure. It is also the only site to offer the FDA-approved TAH in the region.

Read more

BSW researcher co-authors paper in JAMA Oncology examining Hypofractionated Image-Guided Radiotherapy (IGRT) for non-small cell lung cancer patients

Concurrent radiation therapy and chemotherapy, known as chemoradiation, is a common treatment for locally advanced cancers. Adding concurrent chemotherapy can improve the effectiveness of radiation therapy but can also enhance the appearance of toxic side effects. This means that some cancer patients, especially those with comorbidities or poor health status, are ineligible for concurrent chemoradiation. Researchers at Baylor Scott & White Research Institute (BSWRI) are contributing to critical clinical trials to improve the effectiveness of radiation therapy for cancer patients, including those who are not eligible for concurrent chemoradiation.

Read more